Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Development of Acute Renal Failure in Critically Ill Patients

NCT00316576 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT00316576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00316576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Development of Acute Renal Failure in Critically Ill Patients
Lead sponsor
University Hospital, Caen
Phase
Observational
Overall status
Terminated
Start date
May 31, 2006
Completion date
November 30, 2006
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, kidney failure, acute